Doctor profile · Federal record
Dr. ANITA THARIAN, DO
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · Hematology & Oncology Physician · MESQUITE, TX
- NPI 1457367112
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
18601 LBJ FWY STE 315
MESQUITE, TX 751505612
(469) 547-6541
fax (469) 547-6545
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- November 14, 2011
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #M0588
- Medicaid (3)
- TX #173978101 · TX #173978103 · TX #173978104
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457367112. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
37,980
Distinct HCPCS
10
Medicare allowed
$1,177,065
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 24,480 | 20 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 5,041 | 37 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,652 | 26 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 2,201 | 24 | $0 | |
A9595 |
Piflufolastat f-18, diagnostic, 1 millicurie | 845 | 101 | $596 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 479 | 28 | $29 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 276 | 35 | $130 | |
78815 |
Nuclear medicine study from skull base to mid-thigh with ct scan | 203 | 179 | $1,547 | |
77063 |
Screening 3d breast mammography | 167 | 167 | $51 | |
77067 |
Screening mammography | 166 | 166 | $125 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 899. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$950
Transactions
32
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US Inc | 5 | $101.29 | |
| GlaxoSmithKline, LLC. | 3 | $71.79 | |
| PharmaEssentia USA Corporation | 2 | $68.45 | |
| PFIZER INC. | 3 | $60.31 | |
| ABBVIE INC. | 3 | $51.62 | |
| AstraZeneca Pharmaceuticals LP | 2 | $49.20 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $48.72 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $46.49 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.43 | |
| Gilead Sciences, Inc. | 2 | $39.81 | |
| Dendreon Pharmaceuticals LLC | 1 | $34.44 | |
| Rigel Pharmaceuticals, Inc. | 2 | $34.26 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.89 | |
| Sumitomo Pharma America, Inc. | 1 | $28.07 | |
| Merck Sharp & Dohme LLC | 1 | $27.95 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
972
Patients
318
Total drug cost
$638,627
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 232 | 73 | $8,159 |
| Letrozole | Generic | 112 | 38 | $3,350 |
| Alendronate Sodium | Generic | 104 | 31 | $1,187 |
| Tamoxifen Citrate | Generic | 69 | 18 | $2,581 |
| Levothyroxine Sodium | Generic | 62 | 23 | $899 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | Brand | 59 | 21 | $1,316 |
| Eliquis (Apixaban) | Brand | 48 | 0 | $36,921 |
| Prochlorperazine Maleate | Generic | 45 | 29 | $698 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 40 | 15 | $1,168 |
| Gabapentin | Generic | 38 | 16 | $648 |